Key facts
- It has raised $7.0M; the latest was Early Stage VC ($7.0M) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for GuanYueMeiTai
- ·The full record, as it builds
Funding rounds
No funding rounds for GuanYueMeiTai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GuanYueMeiTai
Developer of biomedical research and diagnostic support tools designed for clinical and laboratory applications. The company provides solutions that include molecular detection technologies, reagent formulation, sample processing systems, and data analysis interfaces, enabling healthcare institutions, research laboratories, and diagnostic service providers to conduct precise testing, streamline workflows, and enhance the reliability and reproducibility of biomedical investigations.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
GuanYueMeiTai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GuanYueMeiTai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GuanYueMeiTai in its N-PORT filings yet. We sweep new filings monthly.